Who owns Rapport Therapeutics, Inc. Common Stock?
Institutional ownership of RAPP from SEC Form 13F filings across 112 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
112
13F holders
$1.03B
value, 2026 filers
53.5%
of shares outstanding (25.6M sh)
18
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of RAPP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 7.2M | $298.9M | 0.0% | 15% | +0.1% |
| 2 | Capital International Investors | 2.9M | $121.8M | 0.0% | 6.1% | -5.7% |
| 3 | GOLDMAN SACHS GROUP INC | 2.9M | $121.3M | 0.0% | 6.1% | -1.1% |
| 4 | BlackRock, Inc. | 2.7M | $112.5M | 0.0% | 5.6% | +7.7% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | $56.1M | 0.0% | 2.8% | -49.2% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 793,453 | $33.1M | 0.0% | 1.7% | +10.0% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 787,446 | $32,814 | 0.0% | 1.6% | -9.1% |
| 8 | ALLIANCEBERNSTEIN L.P. | 693,384 | $21.7M | 0.0% | 1.4% | -4.7% |
| 9 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 644,082 | $26.8M | 0.0% | 1.3% | -29.9% |
| 10 | Capital World Investors | 551,657 | $23.0M | 0.0% | 1.2% | +2.8% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | 359,944 | $15.0M | 0.0% | 0.8% | +12.2% |
| 12 | Candriam S.C.A. | 347,650 | $14.5M | 0.1% | 0.7% | +87.0% |
| 13 | MORGAN STANLEY | 297,612 | $12.4M | 0.0% | 0.6% | +79.3% |
| 14 | NORTHERN TRUST CORP | 277,305 | $11.6M | 0.0% | 0.6% | +16.5% |
| 15 | Burkehill Global Management, LP | 250,000 | $10.4M | 0.4% | 0.5% | 0.0% |
| 16 | Sixth Street Partners Management Company, L.P.NEW | 246,815 | $10.3M | 1.8% | 0.5% | new |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 246,815 | $10.3M | 0.0% | 0.5% | +2.9% |
| 18 | Invesco Ltd. | 215,236 | $9.0M | 0.0% | 0.5% | +25.3% |
| 19 | D. E. Shaw & Co., Inc. | 214,831 | $9.0M | 0.0% | 0.4% | +22.4% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 208,333 | $8.7M | 0.0% | 0.4% | +10.1% |
| 21 | MILLENNIUM MANAGEMENT LLC | 154,908 | $6.5M | 0.0% | 0.3% | -51.5% |
| 22 | UBS Group AG | 151,174 | $6.3M | 0.0% | 0.3% | -0.4% |
| 23 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 150,000 | $6.3M | 0.0% | 0.3% | 0.0% |
| 24 | Swedbank AB | 117,400 | $4.9M | 0.0% | 0.2% | +3.7% |
| 25 | Nuveen, LLC | 103,361 | $4.3M | 0.0% | 0.2% | +44.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.